Drug Price Hike Row: Pharma Companies Upset with Minimal Increase

  • Indian pharmaceutical companies are expressing discontent over a minimal price hike allowed for essential medicines in FY25.
  • The National Pharmaceutical Pricing Authority (NPPA) recently approved a negligible increase of only 0.00551% for drugs on the National List of Essential Medicines (NLEM).
  • Pharma companies argue that this minimal increase doesn't account for rising input costs, squeezing profit margins and hindering investments in research and development.
  • The industry has faced several years of low single-digit price increases for NLEM drugs, adding to their concerns.
  • This development could potentially impact the availability and affordability of essential medicines in India.

Comments

Popular posts from this blog

Sky High Surge: IndiGo Soars as India’s Air Passenger Traffic Climbs 8.4% in April

IndiGo Set to Make History: First to Soar from Navi Mumbai Airport with 18 Daily Flights!

RBI’s Record Dividend Bonanza: Government’s Coffers Swell by Rs 2.69 Lakh Crore for FY 2024-25